Avadel Pharmaceuticals Ownership | Who Owns Avadel Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Avadel Pharmaceuticals Ownership Summary


Avadel Pharmaceuticals is owned by 81.02% institutional investors, 4.79% insiders, and 14.19% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.21% of AVDL shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.81% of its assets in Avadel Pharmaceuticals shares.

AVDL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAvadel Pharmaceuticals81.02%4.79%14.19%
SectorHealthcare Stocks 42.03%10.80%47.17%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.97M7.21%$106.49M
Vanguard group5.61M5.80%$85.61M
Brandes investment partners, lp5.44M5.63%$83.14M
Two seas capital lp5.37M5.55%$81.99M
Gendell jeffrey l5.31M5.49%$81.16M
Polar capital4.00M4.13%$61.07M
Vivo capital2.68M2.77%$40.99M
State street2.29M2.37%$35.01M
Wealth effects2.29M2.37%$34.95M
Morgan stanley2.26M2.34%$34.49M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Wealth effects2.29M11.24%$34.95M
Krensavage asset management955.86K6.22%$14.60M
Knoll capital management600.00K5.68%$8.44M
Lion point capital, lp59.70K5.18%$911.62K
Vivo capital2.68M3.30%$40.99M
Tri locum partners lp724.86K2.54%$11.07M
Knott david m jr363.00K2.24%$5.54M
Iridian asset management llc/ct249.59K1.50%$3.81M
Gendell jeffrey l5.31M1.49%$81.16M
Samsara biocapital675.50K1.35%$10.31M

Top Buyers

HolderShares% AssetsChange
Morgan stanley2.26M0.00%1.07M
Kennedy capital management1.63M0.55%645.55K
Marshall wace, llp525.71K0.01%525.71K
Wellington management group llp554.49K0.00%516.19K
Jane street group559.58K0.00%475.06K

Top Sellers

HolderShares% AssetsChange
Janus henderson group---12.92M
Rtw investments, lp---8.80M
Braidwell lp---4.11M
Adage capital partners gp---1.91M
Millennium management---1.81M

New Positions

HolderShares% AssetsChangeValue
Algert global182.59K0.05%182.59K$2.79M
Penserra capital management126.13K0.02%126.13K$1.93M
Rfg advisory73.94K0.02%73.94K$1.13M
Hap trading68.96K0.07%68.96K$1.05B
Quantbot technologies lp48.29K0.02%48.29K$737.39K

Sold Out

HolderChange
Principal securities-9.00
Zurcher kantonalbank (zurich cantonalbank)-19.00
Stephens consulting-45.00
Fortitude family office-55.00
Bell investment advisors-62.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251919.14%78,368,614-2.77%811.16%974.30%5510.00%
Jun 30, 2025173-6.99%80,562,7284.59%831.31%92-7.07%48-2.04%
Mar 31, 20251855.71%77,012,100-3.02%791.17%9911.24%486.67%
Dec 31, 20242-60.00%137,001-87.20%-11.52%----100.00%
Sep 30, 20245-50.00%1,070,001-84.77%11.89%--100.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc3.69M3.81%-
Vanguard US Total Market Shares ETF2.99M3.09%-
Vanguard Total Stock Mkt Idx Inv2.87M2.97%-63.75K
Janus Henderson Global Life Sciences D2.27M2.35%-178.86K
Janus Henderson Global Life Sciences2.27M2.35%-207.97K
iShares Russell 2000 ETF2.15M2.21%-
Janus Global Life Science AUSD1.89M1.95%-131.51K
Janus Henderson Glb Life Scn I2 USD1.72M1.78%-159.56K
Polar Capital Biotech S Inc1.50M1.56%-
Janus Henderson US Small Cap Growth MA1.48M1.54%1.48M

Recent Insider Transactions


DateNameRoleActivityValue
Jan 21, 2025Palczuk Linda-Buy$39.64K
Jan 13, 2025Thornton Peter J.-Buy$80.45K
Jan 13, 2025Ende Eric J-Buy$235.22K
Dec 13, 2024MCHUGH THOMAS S Chief Financial OfficerBuy$24.02K
Dec 11, 2024MCHUGH THOMAS S Chief Financial OfficerBuy$52.43K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q13-
2024 Q47-
2024 Q3--

AVDL Ownership FAQ


Who Owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals shareholders are primarily institutional investors at 81.02%, followed by 4.79% insiders and 14.19% retail investors. The average institutional ownership in Avadel Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Avadel Pharmaceuticals exceeds.

Who owns the most shares of Avadel Pharmaceuticals?

Avadel Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (6.97M shares, 7.21%), Vanguard group (5.61M shares, 5.80%), and Brandes investment partners, lp (5.44M shares, 5.63%). Together, they hold 18.63% of Avadel Pharmaceuticals’s total shares outstanding.

Does Blackrock own Avadel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Avadel Pharmaceuticals.

Who is Avadel Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Wealth effects is Avadel Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.24% of its assets in 2.29M Avadel Pharmaceuticals shares, valued at 34.95M$.

Who is the top mutual fund holder of Avadel Pharmaceuticals shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Avadel Pharmaceuticals shares, with 3.81% of its total shares outstanding invested in 3.69M Avadel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools